Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy

Cardiovascular adverse events induced by immune checkpoint inhibitors (ICIs) have gained significant interest over the past decade due to their impact on short- and long-term outcomes. They were initially thought to be rare, but the increasing use of ICIs in the treatment of both advanced and early...

Descripción completa

Detalles Bibliográficos
Autores principales: Delombaerde, D., Vervloet, D., Franssen, C., Croes, L., Gremonprez, F., Prenen, H., Peeters, M., Vulsteke, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287144/
https://www.ncbi.nlm.nih.gov/pubmed/34271309
http://dx.doi.org/10.1016/j.esmoop.2021.100216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287144/
https://www.ncbi.nlm.nih.gov/pubmed/34271309
http://dx.doi.org/10.1016/j.esmoop.2021.100216

Ejemplares similares